These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9433446)

  • 61. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
    Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Short-acting beta2-agonists.
    Lee T; Dennis S
    Lancet; 2000 Sep; 356(9233):940-1. PubMed ID: 11036917
    [No Abstract]   [Full Text] [Related]  

  • 63. [Salbutamol in chronic bronchial asthma].
    Blankstein A; Spitzer S
    Harefuah; 1973 Jun; 84(12):655-8. PubMed ID: 4147336
    [No Abstract]   [Full Text] [Related]  

  • 64. The long and short of beta2-agonists.
    Lötvall J
    Pulm Pharmacol Ther; 2002; 15(6):497-501. PubMed ID: 12493336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effects of a beta-adrenergic stimulant: Salbutamol, on spontaneous or induced bronchial obstruction in asthma].
    Orehek J; Gayrard P; Charpin J
    Mars Med; 1972; 109(11):713-7. PubMed ID: 4145413
    [No Abstract]   [Full Text] [Related]  

  • 66. The FDA and safe use of long-acting beta-agonists in the treatment of asthma.
    Chowdhury BA; Dal Pan G
    N Engl J Med; 2010 Apr; 362(13):1169-71. PubMed ID: 20181964
    [No Abstract]   [Full Text] [Related]  

  • 67. Overlooking of Cochrane reviews in asthma research.
    Cates C
    Lancet; 2000 Jan; 355(9197):70. PubMed ID: 10615916
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of asthma with beta-adrenergic drugs.
    Kerrebijn KF
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(5):287-9. PubMed ID: 2576903
    [No Abstract]   [Full Text] [Related]  

  • 69. The use of adrenergic bronchodilators in children.
    Bierman CW
    Chest; 1978 Jun; 73(6 Suppl):1005-6. PubMed ID: 28206
    [No Abstract]   [Full Text] [Related]  

  • 70. Beta-receptor agonists in respiratory disease: a summary.
    Clark TJ
    Life Sci; 1993; 52(26):2193-7. PubMed ID: 8099700
    [No Abstract]   [Full Text] [Related]  

  • 71. Long-acting β-agonists and asthma: the saga continues.
    Dixon AE
    Am J Respir Crit Care Med; 2011 Dec; 184(11):1220-1. PubMed ID: 22162879
    [No Abstract]   [Full Text] [Related]  

  • 72. Of mice and men-the curious tale of β blockers in asthma.
    Lipworth B; Jabbal S
    Lancet Respir Med; 2016 Feb; 4(2):89-91. PubMed ID: 26868622
    [No Abstract]   [Full Text] [Related]  

  • 73. Beta-agonists and asthma research: an international consultation.
    Ernst P; Spitzer WO; Suissa S; Cockroft DW; Buist AS
    Eur Respir J; 1993 Feb; 6(2):273-8. PubMed ID: 8095241
    [No Abstract]   [Full Text] [Related]  

  • 74. [beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League].
    Gillissen A; Berdel D; Buhl R; Crieé CP; Kardos P; Magnussen H; Rabe KF; Rolke M; Vogelmeier C; Worth H; Virchow JC
    Dtsch Med Wochenschr; 2007 Jan; 132(1-2):33-9. PubMed ID: 17187322
    [No Abstract]   [Full Text] [Related]  

  • 75. [Sensory-nerves and airway inflammation: interaction with beta-2-adrenoceptor agonists].
    Advenier C; Faisy C; Naline E; Planquette B; Devillier P
    Ann Pharm Fr; 2007 Jul; 65(4):220-7. PubMed ID: 17652989
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The β-adrenergic theory of bronchial asthma: 50 years later.
    Camoretti-Mercado B; Lockey RF
    J Allergy Clin Immunol; 2019 Nov; 144(5):1166-1168. PubMed ID: 31344383
    [No Abstract]   [Full Text] [Related]  

  • 77. Beta 2-adrenoceptor-agonists--potential problems: "development of tachyphylaxis".
    Svedmyr N
    Monaldi Arch Chest Dis; 1993; 48(3):254-61. PubMed ID: 8103695
    [No Abstract]   [Full Text] [Related]  

  • 78. Functional antagonism: tolerance produced by inhaled beta 2 agonists.
    Cockcroft DW; Swystun VA
    Thorax; 1996 Oct; 51(10):1051-6. PubMed ID: 8984693
    [No Abstract]   [Full Text] [Related]  

  • 79. Discriminating measures of bronchodilator drug efficacy and potency.
    Buck H; Parry-Billings M
    Br J Clin Pharmacol; 2001 Sep; 52(3):245-53. PubMed ID: 11560556
    [No Abstract]   [Full Text] [Related]  

  • 80. Relationship between pollen concentrations and short-acting β
    Caillaud DM; Martin S; Ségala C; Evrard B; Adrouche N
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31073083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.